Cargando…

Correction: CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy

Detalles Bibliográficos
Autores principales:	Kinstrie, Ross, Horne, Gillian A., Morrison, Heather, Irvine, David, Munje, Chinmay, Castañeda, Eduardo Gómez, Moka, Hothri A., Dunn, Karen, Cassels, Jennifer E., Parry, Narissa, Clarke, Cassie J., Scott, Mary T., Clark, Richard E., Holyoake, Tessa L., Wheadon, Helen, Copland, Mhairi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076018/ https://www.ncbi.nlm.nih.gov/pubmed/32005922 http://dx.doi.org/10.1038/s41375-020-0721-4

Ejemplares similares

CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy
por: Kinstrie, Ross, et al.
Publicado: (2020)

Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia
por: Irvine, David A., et al.
Publicado: (2016)

The application of BH3 mimetics in myeloid leukemias
por: Parry, Narissa, et al.
Publicado: (2021)

BH3 mimetics in combination with nilotinib or ponatinib represent a promising therapeutic strategy in blast phase chronic myeloid leukemia
por: Parry, Narissa, et al.
Publicado: (2022)

Tyrosine Kinase Inhibitor Independent Gene Expression Signature in CML Offers New Targets for LSPC Eradication Therapy
por: Gómez-Castañeda, Eduardo, et al.
Publicado: (2022)

Targeting self-renewal pathways in myeloid malignancies
por: Sands, William A, et al.
Publicado: (2013)

Chronic myeloid leukaemia cells require the bone morphogenic protein pathway for cell cycle progression and self-renewal
por: Toofan, Parto, et al.
Publicado: (2018)

Preclinical approaches in chronic myeloid leukemia: from cells to systems
por: Clarke, Cassie J., et al.
Publicado: (2017)

Trib2 expression in granulocyte-monocyte progenitors drives a highly drug resistant acute myeloid leukaemia linked to elevated Bcl2
por: O’Connor, Caitriona, et al.
Publicado: (2018)

Targeting quiescent leukemic stem cells using second generation autophagy inhibitors
por: Baquero, Pablo, et al.
Publicado: (2018)

Interrogation of novel CDK2/9 inhibitor fadraciclib (CYC065) as a potential therapeutic approach for AML
por: Chantkran, Wittawat, et al.
Publicado: (2021)

Correction to: Interrogation of novel CDK2/9 inhibitor fadraciclib (CYC065) as a potential therapeutic approach for AML
por: Chantkran, Wittawat, et al.
Publicado: (2021)

The Spliceosome: A New Therapeutic Target in Chronic Myeloid Leukaemia
por: Lebecque, Benjamin, et al.
Publicado: (2022)

A Novel Therapeutic Strategy for the Treatment of Glioma, Combining Chemical and Molecular Targeting of Hsp90α
por: Mehta, Adi, et al.
Publicado: (2011)

PKCβ Facilitates Leukemogenesis in Chronic Lymphocytic Leukaemia by Promoting Constitutive BCR-Mediated Signalling
por: Hay, Jodie, et al.
Publicado: (2022)

Treatment of blast phase chronic myeloid leukaemia: A rare and challenging entity
por: Copland, Mhairi
Publicado: (2022)

The Antiproliferative Activity of Kinase Inhibitors in Chronic Myeloid Leukemia Cells Is Mediated by FOXO Transcription Factors
por: Pellicano, Francesca, et al.
Publicado: (2014)

Differentiated cytoplasmic granule formation in quiescent and non-quiescent cells upon chronological aging
por: Lee, Hsin-Yi, et al.
Publicado: (2016)

Hedgehog signaling in cancer stem cells: a focus on hematological cancers
por: Campbell, Victoria, et al.
Publicado: (2015)

The Bone Marrow Immune Microenvironment in CML: Treatment Responses, Treatment-Free Remission, and Therapeutic Vulnerabilities
por: Patterson, Shaun David, et al.
Publicado: (2023)

Caloric restriction causes a distinct reorganization of the lipidome in quiescent and non-quiescent cells of budding yeast
por: Mohammad, Karamat, et al.
Publicado: (2021)

Dual targeting of p53 and c-Myc selectively eliminates leukaemic stem cells
por: Abraham, Sheela A, et al.
Publicado: (2016)

Assembling defenses against therapy-resistant leukemic stem cells: Bcl6 joins the ranks
por: Pellicano, Francesca, et al.
Publicado: (2011)

Dynamics and structure of quiescent solar prominences
por: Priest, E
Publicado: (1988)

The Quiescent Period in Acute Abdominal Affections
Publicado: (1902)

On the collision of rods in a quiescent fluid
por: Słomka, Jonasz, et al.
Publicado: (2020)

Maintenance of quiescent oocytes by noradrenergic signals
por: Kim, Jeongho, et al.
Publicado: (2021)

The Epigenetic Regulation of Quiescent in Stem Cells
por: Radak, Mehran, et al.
Publicado: (2023)

Secondary Processes Dominate the Quiescent, Spontaneous Aggregation of α-Synuclein at Physiological pH with Sodium Salts
por: Horne, Robert I., et al.
Publicado: (2023)

El 93
por: Hugo, Victor, 1802-1885

Jasowiec '93
Publicado: (1993)

SIGGRAPH '93
por: Cunningham, S
Publicado: (1993)

Strings '93
por: Halpern, Martin B, et al.
Publicado: (1995)

Safewaste '93
Publicado: (1993)

HIPAGS '93
Publicado: (1993)

Lasers '93
Publicado: (1993)

Improving outcomes in chronic myeloid leukemia through harnessing the immunological landscape
por: Hsieh, Ya-Ching, et al.
Publicado: (2021)

PSB93#16 Conversion Booster Milestone Décembre 93
por: Arruat, M, et al.
Publicado: (1993)

SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells
por: Descours, Benjamin, et al.
Publicado: (2012)

The Causes of Relapse in Quiescent Cases of Pulmonary Tuberculosis
por: Clarke, Brice R.
Publicado: (1948)

Cannot write session to /tmp/vufind_sessions/sess_grmu1ucd1vve20gjvo3u9bhmr8